Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Tempus, Pfizer Enter Strategic AI Alliance in Oncology | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Tempus, Pfizer Enter Strategic AI Alliance in Oncology

Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights for therapeutic development.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Tempus, a provider in artificial intelligence (AI) and precision medicine, has entered a multi-year, strategic collaboration with Pfizer to further AI and machine learning-driven efforts in therapeutic development. The collaboration aims to more precisely gather insights that will inform novel drug discovery and development in oncology.
 
Through this collaboration, Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights for therapeutic development in oncology. Pfizer also has access to Tempus’ capabilities that support therapeutic R&D, to advance its own oncology portfolio, including AI-driven companion diagnostic offerings and Tempus’ clinical trial matching program, TIME, that rapidly activates studies for patients in communities across the country.
 
“Pfizer shares our commitment to bringing novel treatments to patients faster, and we look forward to working together to usher in the next generation of oncology therapeutics,” said Eric Lefkofsky, Founder and CEO of Tempus. “This is the third strategic collaboration Tempus has established with a global pharmaceutical leader in the last year, as we believe that combining our technological capabilities with pharma’s deep R&D expertise will get us much closer in realizing the full potential of precision medicine.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics